Brief: Statera Biopharma Receives Notice From Nasdaq That Co No Longer Meets Minimum Bid Price Requirements
25/03/2022 20:12
March 25 (Reuters) - Statera Biopharma Inc STAB.O :
* STATERA BIOPHARMA INC - ON MARCH 23, CO RECEIVED NOTICE
FROM
NASDAQ INDICATING THAT CO NO LONGER MEETS MINIMUM BID PRICE
REQUIREMENTS
Further company coverage: STAB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc